Quarterly report pursuant to Section 13 or 15(d)

Restructuring and Related Impairments - Summary of Restructuring Expenses (Details)

v3.24.3
Restructuring and Related Impairments - Summary of Restructuring Expenses (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Restructuring Cost and Reserve [Line Items]        
Total $ 1.8 $ (0.1) $ 4.7 $ 1.6
Operating Segments | Medical        
Restructuring Cost and Reserve [Line Items]        
Total 1.8 0.0 4.2 0.3
Operating Segments | Technologies        
Restructuring Cost and Reserve [Line Items]        
Total 0.0 0.0 0.5 0.2
Corporate and other        
Restructuring Cost and Reserve [Line Items]        
Total $ 0.0 $ (0.1) $ 0.0 $ 1.1